Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sangamo Therapeutics (SGMO) Depreciation & Amortization (CF) (2016 - 2025)

Sangamo Therapeutics (SGMO) has disclosed Depreciation & Amortization (CF) for 16 consecutive years, with $998000.0 as the latest value for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) fell 19.58% year-over-year to $998000.0; the TTM value through Dec 2025 reached $4.0 million, down 21.68%, while the annual FY2025 figure was $4.0 million, 21.68% down from the prior year.
  • Depreciation & Amortization (CF) hit $998000.0 in Q4 2025 for Sangamo Therapeutics, up from $989000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $5.5 million in Q3 2023 and bottomed at $989000.0 in Q3 2025.
  • Average Depreciation & Amortization (CF) over 5 years is $2.3 million, with a median of $2.1 million recorded in 2021.
  • Year-over-year, Depreciation & Amortization (CF) surged 87.87% in 2021 and then plummeted 77.83% in 2024.
  • Sangamo Therapeutics' Depreciation & Amortization (CF) stood at $2.8 million in 2021, then increased by 20.66% to $3.3 million in 2022, then crashed by 45.22% to $1.8 million in 2023, then tumbled by 32.07% to $1.2 million in 2024, then decreased by 19.58% to $998000.0 in 2025.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods came in at $998000.0, $989000.0, and $993000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.